MDxHealth SA
MDXH | BR
Overview
Corporate Details
- ISIN(s):
- BE0974461940
- LEI:
- 549300J3MG9F9B5FY646
- Country:
- Belgium
- Address:
- Rue d'Abhooz 31, 4040 Herstal
- Website:
- https://mdxhealth.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Mdxhealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on proprietary genetic, epigenetic and other complex molecular technologies. Mdxhealth is dedicated to providing highly accurate and clinically actionable urologic solutions to inform patient diagnosis and treatment while improving healthcare economics for payers and providers.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2023-12-18 07:00 |
Regulatory News Service
MDXH PR EN.pdf
|
English | 241.9 KB | |
| 2023-12-18 07:00 |
Regulatory News Service
MDXH PR FR.pdf
|
French | 236.7 KB | |
| 2023-11-27 07:00 |
Regulatory News Service
PR 2023 10 27 EN.pdf
|
English | 249.4 KB | |
| 2023-11-27 07:00 |
Regulatory News Service
PR 2023 10 27 FR.pdf
|
French | 241.5 KB | |
| 2023-11-13 22:00 |
Major Shareholding Notification
MDxHealth - New Denominator (EN).pdf
|
English | 249.5 KB | |
| 2023-11-13 22:00 |
Major Shareholding Notification
MDxHealth - New Denominator (FR).pdf
|
French | 250.1 KB | |
| 2023-11-08 22:00 |
Earnings Release
MDxHealth 3Q23 FINAL EN.pdf
|
English | 288.9 KB | |
| 2023-11-08 22:00 |
Earnings Release
MDxHealth 3Q23 FINAL FR.pdf
|
French | 299.0 KB | |
| 2023-11-06 07:00 |
Declaration of Voting Results & Voting Rights Announcements
EGM results and process (FR).pdf
|
French | 261.5 KB | |
| 2023-11-06 07:00 |
Regulatory News Service
EGM results and process (ENG).pdf
|
English | 259.2 KB | |
| 2023-11-06 07:00 |
General Meeting Notice
EGM Deed (3 November 2023).pdf
|
French | 4.3 MB | |
| 2023-11-06 07:00 |
Regulatory News Service
EGM results and process (ENG).pdf
|
English | 259.2 KB | |
| 2023-11-06 07:00 |
Inside Information Statement
EGM results and process (FR).pdf
|
French | 261.5 KB | |
| 2023-10-20 22:00 |
Major Shareholding Notification
MDxHealth - Press Release (ENG).pdf
|
English | 210.7 KB | |
| 2023-10-20 22:00 |
Transaction in Own Shares
MDxHealth - Press Release (FR).pdf
|
French | 212.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2020-09-15 | SLAGMULDER REGINE | Board | Buy | 11,802 | 8,408.92 EUR |
| 2020-09-15 | Sollee Joseph | Executive member | Buy | 98,000 | N/A |
| 2020-09-11 | SLAGMULDER REGINE | Board | Buy | 14,202 | 10,079.16 EUR |
| 2020-09-10 | SLAGMULDER REGINE | Board | Buy | 16,000 | 11,387.20 EUR |
| 2020-09-08 | SLAGMULDER REGINE | Board | Buy | 15,560 | 11,077.16 EUR |
| 2020-09-07 | SLAGMULDER REGINE | Board | Buy | 7,766 | 5,510.75 EUR |
| 2020-09-04 | SLAGMULDER REGINE | Board | Buy | 18,599 | 13,205.00 EUR |
| 2019-12-17 | Sollee Joseph | Executive member | Sell | 50,777 | 49,786.85 EUR |
| 2019-09-27 | Mariën Rudi | Close relation | Buy | 2,211,765 | 1,880,000.25 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |